Pharmacia man tipped to head Celltech
October 22, 2003Pharmacia's Head of Research and Development, Goran Ando, is tipped to become Celltech's new Chief Executive when its current incumbent …
Pharma marketing’s changing skills set
October 21, 2003Business Services, Sales and Marketing marketing, recruitment, skills
Sales and marketing are undergoing something of a revolution as the pharmaceutical industry reacts to a multitude of challenges. Waning …
New FDA head promises improvements for workforce
October 21, 2003The new FDA Commissioner, Dr Mark McClellan, has pledged that improvements in the working lives of staff will be a …
WTO close to agreeing medicines supply deal
October 21, 2003World Trade Organisation ministers say they are close to striking a deal aimed at improving the provision of medicines to …
Local people to control foundation hospitals
October 21, 2003Local people are to play a major role in deciding how the new, more autonomous foundation hospitals are to be …
‘Smart’ cancer drugs share top honours in drug innovation prize
October 21, 2003prix galien
The innovative science behind two breakthrough cancer drugs, Novartis’ leukaemia treatment Glivec and Roche’s breast cancer drug Herceptin, has been …
Novartis questions AstraZeneca cancer data
October 21, 2003Novartis has questioned the evidence behind a UK licence extension to AstraZeneca breast cancer drug Arimidex.The Medicines Control Agency licence …
Kogan steps down from troubled Schering
October 21, 2003Richard Jay Kogan has stepped down as Chairman of Schering-Plough and will relinquish his post as Chief Executive and President …
Cozaar gains renal protection licence
October 21, 2003Merck Sharpe & Dohme's Cozaar has gained a new UK licence for renal protection in patients with type II diabetes …
Lilly to launch three products in 2003
October 21, 2003Eli Lilly is to embark on an ambitious product launch schedule over the next two years to overcome the patent …
Bayer open to takeover bids
October 21, 2003The Chief Executive of Bayer has conceded the company cannot continue alone, and has now declared the company open to …
Alzheimer drugs rationing continues despite NICE guidelines
October 21, 2003Alzheimer's patients in a quarter of all health authorities are still not receiving the latest medicines despite NICE guidance being …
Europe to mimic US research ‘clusters’
October 21, 2003New networks of excellence in pharmaceutical research must be established if Europe is to catch up with world leading US …
Crestor approval lifts AstraZeneca
October 21, 2003AstraZeneca has been boosted by the first regulatory approval in the Netherlands of Crestor, its 'superstatin' cholesterol treatment.The drug is …
Latest content
FibroFind appoints Lee Borthwick as CEO
